Literature DB >> 11872155

Phospholipase A2.

Makoto Murakami1, Ichiro Kudo.   

Abstract

Phospholipase A2 (PLA2) catalyzes the hydrolysis of the sn-2 position of membrane glycerophospholipids to liberate arachidonic acid (AA), a precursor of eicosanoids including prostaglandins (PGs) and leukotrienes (LTs). The same reaction also produces lysophosholipids, which represent another class of lipid mediators. So far, at least 19 enzymes that possess PLA2 activity have been identified in mammals. The secretory PLA2 (sPLA2) family, in which 10 isozymes have been identified, consists of low-molecular-weight, Ca2+-requiring, secretory enzymes that have been implicated in a number of biological processes, such as modification of eicosanoid generation, inflammation, host defense, and atherosclerosis. The cytosolic PLA2 (cPLA2) family consists of 3 enzymes, among which cPLA2alpha plays an essential role in the initiation of AA metabolism. Intracellular activation of cPLA2alpha is tightly regulated by Ca2+ and phosphorylation. The Ca2+-independent PLA2 (iPLA2) family contains 2 enzymes and may play a major role in membrane phospholipid remodeling. The platelet-activating factor (PAF) acetylhydrolase (PAF-AH) family represents a unique group of PLA2 that contains 4 enzymes exhibiting unusual substrate specificity toward PAF and/or oxidized phospholipids. In this review, we will overview current understanding of the properties and functions of each enzyme belonging to the sPLA2, cPLA2, and iPLA2 families, which have been implicated in signal transduction.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11872155     DOI: 10.1093/oxfordjournals.jbchem.a003101

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  131 in total

Review 1.  New weapons against inflammation: dual inhibitors of phospholipase A2 and transglutaminase.

Authors:  Lucio Miele
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

Review 2.  Membrane biophysics and mechanics in Alzheimer's disease.

Authors:  Xiaoguang Yang; Sholpan Askarova; James C-M Lee
Journal:  Mol Neurobiol       Date:  2010-05-01       Impact factor: 5.590

3.  Biological and structural characterization of a new PLA2 from the Crotalus durissus collilineatus venom.

Authors:  M H Toyama; D O Toyama; Paulo P Joazeiro; E M Carneiro; L O S Beriam; L S Marangoni; A C Boschero
Journal:  Protein J       Date:  2005-02       Impact factor: 2.371

Review 4.  Neuroinflammation and synaptic loss.

Authors:  Jagadeesh S Rao; Matthew Kellom; Hyung-Wook Kim; Stanley I Rapoport; Edmund A Reese
Journal:  Neurochem Res       Date:  2012-02-07       Impact factor: 3.996

5.  Molecular cloning, expression, and characterization of secretory phospholipase A2 in tobacco.

Authors:  Ritsuko Fujikawa; Yukichi Fujikawa; Noriaki Iijima; Muneharu Esaka
Journal:  Lipids       Date:  2005-09       Impact factor: 1.880

Review 6.  Role of LPS-elicited signaling in triggering gastric mucosal inflammatory responses to H. pylori: modulatory effect of ghrelin.

Authors:  B L Slomiany; A Slomiany
Journal:  Inflammopharmacology       Date:  2017-05-17       Impact factor: 4.473

7.  Calcium-independent phospholipase A2γ enhances activation of the ATF6 transcription factor during endoplasmic reticulum stress.

Authors:  Hanan Elimam; Joan Papillon; Tomoko Takano; Andrey V Cybulsky
Journal:  J Biol Chem       Date:  2014-12-09       Impact factor: 5.157

Review 8.  Integration of cytokine biology and lipid metabolism in stroke.

Authors:  Rao Muralikrishna Adibhatla; Robert Dempsy; James Franklin Hatcher
Journal:  Front Biosci       Date:  2008-01-01

9.  Complement-mediated activation of calcium-independent phospholipase A2γ: role of protein kinases and phosphorylation.

Authors:  Hanan Elimam; Joan Papillon; Tomoko Takano; Andrey V Cybulsky
Journal:  J Biol Chem       Date:  2012-12-20       Impact factor: 5.157

10.  Secretory phospholipase A2 induces dendritic cell maturation.

Authors:  Laure Perrin-Cocon; Sophie Agaugué; Frédéric Coutant; Aurélie Masurel; Sofiane Bezzine; Gérard Lambeau; Patrice André; Vincent Lotteau
Journal:  Eur J Immunol       Date:  2004-08       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.